Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00185120 · ClinicalTrials.gov registry record · Phase 4
Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel Blocker
A Phase 4 study, sponsored by Daiichi Sankyo.
- Completed
- Registry status
- Phase 4
- Development phase
- 152
- Enrollment target
NCT00185120 is a Phase 4 study that has completed, run by Daiichi Sankyo. The registered enrollment target is 152 participants.
The verdict
NCT00185120, a Phase 4 study, has completed, sponsored by Daiichi Sankyo.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 152 participants
- Enrollment target
Study Summary
A comparison of 2 different combinations of high blood pressure medications to treat hypertension
Interventions
- DRUG Amlodipine
- DRUG Olmesartan medoxomil
- DRUG Hydroclorothiazide
- DRUG Benazepril
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2005-09 |
| Est. Completion | 2006-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00185120
The ClinicalTrials.gov registry entry for NCT00185120 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 152 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Daiichi Sankyo, which has 236 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Amlodipine is the first listed.
NCT00185120 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00185120 about?
NCT00185120 is a clinical study titled "Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel Blocker". A comparison of 2 different combinations of high blood pressure medications to treat hypertension
What is the current status of trial NCT00185120?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 152 participants. The study started on 2005-09. Estimated completion is 2006-09.
What interventions are being tested in trial NCT00185120?
The interventions under investigation include: Amlodipine (DRUG), Olmesartan medoxomil (DRUG), Hydroclorothiazide (DRUG), Benazepril (DRUG).
Who is sponsoring clinical trial NCT00185120?
This trial is sponsored by Daiichi Sankyo, which has 236 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.